CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like BioPath Holdings
BioPath Holdings logo

BioPath Holdings

biopathholdings.com
BioPath Holdings is an oncology-focused biotechnology company developing antisense RNAi nanoparticle drug candidates to deliver DNA therapeutics directly to cancer cells, with lead candidate prexigebersen (formerly BP1001) in a Phase 2 trial for acute myeloid leukemia.
TECH STACK
CloudflareGoogle AnalyticsWordPressjQuery
Biopathholdings campaignconsultative3000 target
Companies like Biopathholdings
“Primarily a therapeutics developer rather than a seller of a clear B2B commercial product; GTM is investor, clinical, and partnership oriented rather than standard business-buyer ICP driven.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 38
Decision-makers 27
Emails 20
Signals 0

Companies like BioPath Holdings — competitors and alternatives

CompanyWhat they doLocationSizeHiring
BioPath Holdingsbiopathholdings.com
BioPath Holdings is an oncology-focused biotechnology company developing antisense RNAi nanoparticle drug candidates to deliver DN
Ionis Pharmaceuticalsionis.com
JEJPJR
Ionis Pharmaceuticals is a biotechnology company that invents and delivers RNA- and DNA-targeted medicines for people living with Carlsbad, California1001-5000
EMVJHA
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNAi therapeutics, developing medicines that silenceCambridge, Massachusetts1001-5000
Sirnaomicssirnaomics.com
MHBLMF
Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company that discovers and develops RNA drugs for indications wiGermantown, Maryland11-50
Arrowhead Pharmaceuticalsarrowheadpharma.com
DACLAS
Arrowhead Pharmaceuticals is a biotechnology company developing RNAi therapeutics to treat hard-to-treat diseases, with a TRiM™ RNPasadena, California201-1000
Silence Therapeuticssilence-therapeutics.com
Regulus LLCregulusrx.com
Regulus Therapeutics is a clinical-stage biopharmaceutical company developing and discovering microRNA therapeutics, headquarteredMc Clellanville, South Carolina1-10
Dicerna Pharmaceuticalsdicerna.com
Dicerna Pharmaceuticals is a biotechnology company developing innovative treatments for rare inherited diseases, with operations bLexington, Massachusetts201-1000
Beam Therapeuticsbeamtx.com
BCHMLZ
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a Cambridge, Massachusetts201-1000
Intelliatxintelliatx.com
ASJLRK
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severeCambridge, Massachusetts201-1000
Ionis Pharmaceuticalsionispharma.com
Ionis Pharmaceuticals is a biotechnology company founded in 1989 that specializes in the discovery and development of RNA-targetedCarlsbad, California201-1000
Editas Medicineeditasmedicine.com
GOAGAP
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipelCambridge, Massachusetts51-200
Verve Therapeuticsvervetx.com
LCMFYM
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovasBoston, Massachusetts51-200
CRISPR Therapeuticscrisprtx.com
SGHXGW
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever apprBoston, Massachusetts201-1000
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class mediCambridge, Massachusetts5000+
Regeneronregeneron.com
Regeneron is a biopharmaceutical company that invents, develops, and commercializes life-transforming medicines for people with seTarrytown, New York5000+
Primeeditingprimeediting.com
Precisionbiosciencesprecisionbiosciences.com
Precision BioSciences (Nasdaq: DTIL) is a clinical-stage gene editing company based in Durham, North Carolina, developing in vivo Durham, North Carolina51-200
REGENXBIOregenxbio.com
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene Rockville, Maryland201-1000
OliX Pharmaceuticalsolixpharma.com
OliX Pharmaceuticals is a clinical-stage pharmaceutical company developing RNAi-based therapeutics for locally administrable diseaSuwon-si, Gyeonggi-do51-200
uniQure is a gene therapy company with a modular, validated technology platform that advances a pipeline of proprietary and partneAmsterdam, 1105BP201-1000
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, oSeattle, Washington1-10
Caribou Biosciencescariboubio.com
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using Berkeley, California51-200
Crispertxcrispertx.com
Crispagencrispagen.com
RaNA Therapeuticstranslate.bio
Translate Bio (formerly RaNA Therapeutics) is a biotechnology company based in Cambridge, Massachusetts, that develops and manufacCambridge, Massachusetts11-50
Sangamo Therapeuticssangamo.com
Sangamo Therapeutics is a biotechnology company developing gene-based therapies using proprietary zinc finger technology, includinBrisbane, California201-1000
Wave is a mobile money platform that reimagines mobile money for Africa, offering deposit, withdrawal, bill payments, money transf
Run live for more

Agent activity

Done
$fetch_profilebiopathholdings.com
Found: BioPath Holdings
$analyze_identitybiopathholdings.com
BioPath Holdings is an oncology-focused biotechnology company developing antisense RNAi nanoparticle drug candidates to deliver DNA therapeutics directly to cancer cells, with lead
$search_companiescompanies like BioPath Holdings
24 companies
$search_peopledecision-makers

Frequently asked questions about BioPath Holdings

What does BioPath Holdings do?

BioPath Holdings is an oncology-focused biotechnology company developing antisense RNAi nanoparticle drug candidates to deliver DNA therapeutics directly to cancer cells, with lead candidate prexigebersen (formerly BP1001) in a Phase 2 trial for acute myeloid leukemia.

Who are BioPath Holdings's competitors?

Companies like BioPath Holdings include Ionis Pharmaceuticals, Alnylam, Sirnaomics, Arrowhead Pharmaceuticals, Silence Therapeutics. See the full list of 24 competitors and alternatives above.

Who are the decision-makers at BioPath Holdings?

Key decision-makers and buying contacts at BioPath Holdings are listed above, including leaders across executive, finance, sales and operations.